Well, I must apologize - I thought surely you were scamming me. But, all of
a sudden, my mailbox overflows. I received one order on Thursday, 8 June,
and then another on Saturday, 10 June. Almost 1 month from our first
effort, but the postal service must be the culprits. With this double
supply, you are now going to have to send me a couple of women, so the meds
don't go to waste. How can we make this right? What would you like me to
do? Thanks. I hope only good karma comes to you.
- Curt
In Early, Aggressive RA, Combo Initially Better Than MTX - Medscape
In Early, Aggressive RA, Combo Initially Better Than MTXMedscapeTwo-year data reported by the TEAR investigators online April 16 in Arthritis & Rheumatism indicate that the less expensive triple DMARD regimen (methotrexate [MTX]/sulfasalazine/hydroxychloroquine) is generally as effective as etanercept/MTX and that .
Pfizer's Arthritis Pill Gets Nod from FDA Panel - MedPage Today
Pfizer's Arthritis Pill Gets Nod from FDA PanelMedPage TodayEven some who voted in favor expressed concerns about the possibility that tofacitinib could be used after failure of a single drug such as sulfasalazine or hydroxychloroquine, suggesting that the indication be limited to use after failure of .
IL-17 Blocker Promising for Spondylitis - MedPage Today
IL-17 Blocker Promising for SpondylitisMedPage TodayThey were allowed to continue on stable doses of other medications such as methotrexate, sulfasalazine, and prednisone.
Arthritis Pill Gets Nod from FDA Panel - Everyday Health
Arthritis Pill Gets Nod from FDA PanelEveryday HealthEven some who voted in favor expressed concerns about the possibility that tofacitinib could be used after failure of a single drug such as sulfasalazine or hydroxychloroquine, suggesting that the indication be limited to use after failure of .
Takeda's vedolizumab meets primary endpoints in Ph III Crohn's disease study - The Pharma Letter
Takeda's vedolizumab meets primary endpoints in Ph III Crohn's disease studyThe Pharma LetterUlcerative colitis can be treated with a number of medications including aminosalicylates such as sulfasalazine, corticosteroids such as prednisone, immunosuppressive medications such as azathioprine, and biological agents such as infliximab, .